There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
Katsube, T. et al.: Clin. Pharmacokinet., 55, 1423 (2016); Siegal, D. et al.: Semin. Hematol., 50, S18 (2013);
Synonyms
(2E)-3-[2,6-Dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-2-propenoic Acid-d13; S 888711-d13
Application Notes
Lusutrombopag-d13 is the labelled analogue of Lusutrombopag (L474985), a newly discovered thrombopoietin receptor agonist used in the treatment of patients with chronic ITP.
Hazard Compound
Refer MSDS for complete information.
Overview
Lusutrombopag-d13 is the labelled analogue of Lusutrombopag (L474985), a newly discovered thrombopoietin receptor agonist used in the treatment of patients with chronic ITP.
